Committee Opinion No. 722: Marijuana Use During Pregnancy and Lactation
- PMID: 28937574
- DOI: 10.1097/AOG.0000000000002354
Committee Opinion No. 722: Marijuana Use During Pregnancy and Lactation
Abstract
Cannabis sativa (marijuana) is the illicit drug most commonly used during pregnancy. The self-reported prevalence of marijuana use during pregnancy ranges from 2% to 5% in most studies. A growing number of states are legalizing marijuana for medicinal or recreational purposes, and its use by pregnant women could increase even further as a result. Because of concerns regarding impaired neurodevelopment, as well as maternal and fetal exposure to the adverse effects of smoking, women who are pregnant or contemplating pregnancy should be encouraged to discontinue marijuana use. Obstetrician-gynecologists should be discouraged from prescribing or suggesting the use of marijuana for medicinal purposes during preconception, pregnancy, and lactation. Pregnant women or women contemplating pregnancy should be encouraged to discontinue use of marijuana for medicinal purposes in favor of an alternative therapy for which there are better pregnancy-specific safety data. There are insufficient data to evaluate the effects of marijuana use on infants during lactation and breastfeeding, and in the absence of such data, marijuana use is discouraged.
Comment in
-
Committee Opinion No. 722: Marijuana Use During Pregnancy and Lactation.Obstet Gynecol. 2018 Jan;131(1):164. doi: 10.1097/AOG.0000000000002429. Obstet Gynecol. 2018. PMID: 29266063 No abstract available.
-
In Reply.Obstet Gynecol. 2018 Jan;131(1):164-165. doi: 10.1097/AOG.0000000000002430. Obstet Gynecol. 2018. PMID: 29266064 No abstract available.
Similar articles
-
Committee Opinion Summary NO. 722: Marijuana Use During Pregnancy and Lactation.Obstet Gynecol. 2017 Oct;130(4):931-932. doi: 10.1097/AOG.0000000000002349. Obstet Gynecol. 2017. PMID: 28937569
-
Committee Opinion No. 637: Marijuana Use During Pregnancy and Lactation.Obstet Gynecol. 2015 Jul;126(1):234-8. doi: 10.1097/01.AOG.0000467192.89321.a6. Obstet Gynecol. 2015. PMID: 26241291
-
Marijuana Use in Pregnancy: Concerns in an Evolving Era.J Midwifery Womens Health. 2017 May;62(3):363-367. doi: 10.1111/jmwh.12631. Epub 2017 May 12. J Midwifery Womens Health. 2017. PMID: 28498631
-
Marijuana use in pregnancy and lactation: a review of the evidence.Am J Obstet Gynecol. 2015 Dec;213(6):761-78. doi: 10.1016/j.ajog.2015.05.025. Epub 2015 May 15. Am J Obstet Gynecol. 2015. PMID: 25986032 Review.
-
Cannabis Use and Consequences.Pediatr Clin North Am. 2019 Dec;66(6):1075-1086. doi: 10.1016/j.pcl.2019.08.004. Pediatr Clin North Am. 2019. PMID: 31679598 Review.
Cited by
-
Prenatal Cannabis Exposure and Executive Function and Aggressive Behavior at Age 5 Years.JAMA Pediatr. 2024 Dec 1;178(12):1316-1325. doi: 10.1001/jamapediatrics.2024.4352. JAMA Pediatr. 2024. PMID: 39466284
-
Assessment of the effects of cannabidiol and a CBD-rich hemp extract in Caenorhabditis elegans.Front Toxicol. 2024 Oct 1;6:1469341. doi: 10.3389/ftox.2024.1469341. eCollection 2024. Front Toxicol. 2024. PMID: 39420966 Free PMC article.
-
Perceptions, barriers, and facilitators of cannabis screening during pregnancy and labor: A qualitative study.Drug Alcohol Depend Rep. 2024 Aug 22;12:100274. doi: 10.1016/j.dadr.2024.100274. eCollection 2024 Sep. Drug Alcohol Depend Rep. 2024. PMID: 39280985 Free PMC article.
-
Perceptions of Cannabis Use and Its Benefits and Risks Among Breastfeeding Mothers.Womens Health Rep (New Rochelle). 2024 May 6;5(1):412-423. doi: 10.1089/whr.2024.0021. eCollection 2024. Womens Health Rep (New Rochelle). 2024. PMID: 39035146
-
Potentially modifiable risk and protective factors affecting mental and emotional wellness in pregnancy.Front Hum Neurosci. 2024 Feb 20;18:1323297. doi: 10.3389/fnhum.2024.1323297. eCollection 2024. Front Hum Neurosci. 2024. PMID: 38445095 Free PMC article.
References
-
- El Marroun H, Tiemeier H, Jaddoe VW, Hofman A, Verhulst FC, van den Brink W, et al. Agreement between maternal cannabis use during pregnancy according to self-report and urinalysis in a population-based cohort: the Generation R Study. Eur Addict Res 2011;17:37–43.
-
- van Gelder MM, Reefhuis J, Caton AR, Werler MM, Druschel CM, Roeleveld N. Characteristics of pregnant illicit drug users and associations between cannabis use and perinatal outcome in a population-based study. National Birth Defects Prevention Study. Drug Alcohol Depend 2010;109:243–7.
-
- Passey ME, Sanson-Fisher RW, D’Este CA, Stirling JM. Tobacco, alcohol and cannabis use during pregnancy: clustering of risks. Drug Alcohol Depend 2014;134:44–50.
-
- Beatty JR, Svikis DS, Ondersma SJ. Prevalence and perceived financial costs of marijuana versus tobacco use among urban low-income pregnant women. J Addict Res Ther 2012;3:1000135.
-
- Schempf AH, Strobino DM. Illicit drug use and adverse birth outcomes: is it drugs or context? J Urban Health 2008;85:858–73.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical

